How many insider trades does FilingIQ track for AIMD?

FilingIQ tracks 145 Form 4 insider transactions for AIMD (Ainos, Inc.), covering filings from Dec 6, 2021 onwards. 13 of those were filed in the last 90 days.

Are AIMD insiders net buyers or net sellers?

Across the full Form 4 history for AIMD, 11 transactions (8%) were open-market purchases and 19 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does AIMD insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is AIMD in?

Ainos, Inc. (AIMD) is classified in the Technology sector, specifically Scientific & Technical Instruments, with a current market capitalisation of $9.64M.

AIMD insider trading

NasdaqCM Technology

Ainos, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

145

Last 90 days

Buys / sells

8% / 13%

Market cap

$9.64M

About Ainos, Inc.

Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data. The company is also giving AI for robotics, smart factories, senior care, and women's health. In addition, it develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal health. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.

Company website: www.ainos.com

AIMD insider activity at a glance

FilingIQ has scored 145 insider transactions for AIMD since Dec 6, 2021. The most recent filing in our index is dated May 5, 2026.

Across the full history, 11 open-market purchases and 19 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on AIMD insider trades is 53.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live AIMD trades on FilingIQ Raw filings on SEC EDGAR

Other Technology tickers with recent insider activity

CRWV 1,356

CoreWeave, Inc.

DELL 553

Dell Technologies Inc.

UBER 325

Uber Technologies, Inc

CRWD 298

CrowdStrike Holdings, Inc.

Frequently asked

How many insider trades does FilingIQ track for AIMD?: FilingIQ tracks 145 Form 4 insider transactions for AIMD (Ainos, Inc.), covering filings from Dec 6, 2021 onwards. 13 of those were filed in the last 90 days.
Are AIMD insiders net buyers or net sellers?: Across the full Form 4 history for AIMD, 11 transactions (8%) were open-market purchases and 19 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does AIMD insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is AIMD in?: Ainos, Inc. (AIMD) is classified in the Technology sector, specifically Scientific & Technical Instruments, with a current market capitalisation of $9.64M.

Methodology & sources

Every AIMD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.